Evidence map›Paper›PMID 29552703›Full record

ArticleJournal of industrial microbiology & biotechnology2018

Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.

Mitchell S Weisenberger, Tara L Deans

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Principles of synthetic biology.Essays in biochemistry · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mitchell S WeisenbergerDepartment of Bioengineering, University of Utah, Salt Lake City, UT, 84112, USA.
Tara L DeansDepartment of Bioengineering, University of Utah, Salt Lake City, UT, 84112, USA. tara.deans@utah.edu.ORCID http://orcid.org/0000-0002-2361-2195

Funding

Engineering novel delivery systems with synthetic biologyR21EB025413 · NIBIB · UNIVERSITY OF UTAH · PI DEANS, TARA LYNN · 2018 to 2020
$609k
IMPACT OF TS PROPHYLAXIS ON ANTIFOLATE RESISTANT MALARIAK01TW000014 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI KUBLIN, JAMES G. · 2000 to 2000
$103k
National Institutes of Health 1R21EB025413-01National Science Foundation CBET - 1554017NIBIB NIH HHS R21 EB025413Office of Naval Research ONR - N00014-16-1-3012
6 · The paper itself

Abstract

Synthetic biologists use engineering principles to design and construct genetic circuits for programming cells with novel functions. A bottom-up approach is commonly used to design and construct genetic circuits by piecing together functional modules that are capable of reprogramming cells with novel behavior. While genetic circuits control cell operations through the tight regulation of gene expression, a diverse array of environmental factors within the extracellular space also has a significant impact on cell behavior. This extracellular space offers an addition route for synthetic biologists to apply their engineering principles to program cell-responsive modules within the extracellular space using biomaterials. In this review, we discuss how taking a bottom-up approach to build genetic circuits using DNA modules can be applied to biomaterials for controlling cell behavior from the extracellular milieu. We suggest that, by collectively controlling intrinsic and extrinsic signals in synthetic biology and biomaterials, tissue engineering outcomes can be improved.

Indexed as

Gene Regulatory NetworksTissue EngineeringBiocompatible MaterialsGene Expression Regulation, BacterialGenetic EngineeringHumansSynthetic BiologyTranscription FactorsBiocompatible MaterialsTranscription Factors

Identifiers

PMID29552703
PMCPMC6041164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.